Short term protective effect of digitoxin in sepsis-induced acute lung injury
Erişim
info:eu-repo/semantics/openAccessTarih
2022Yazar
Bora, Ejder SaylavErdogan, MuMIN Alper
Ozkul, Bahattin
Sever, Ibrahim Halil
Sogut, Ibrahim
Hurdag, Canan
Erbas, Oytun
Üst veri
Tüm öğe kaydını gösterÖzet
Purpose: Digitoxin is a cardiac glycoside used in the treatment of heart failure. Inspired by its known antiinflammatory effect, this study aims to investigate the effect of digoxin in a sepsis model and to bring to light its effect and underlying mechanism in acute lung injury (ALI). Method: 28 wistar albino rats were divided into 4 groups. Sepsis model is performed by the feces intraperitoneal-injection procedure (FIP). Results: TNF-a, CRP, IL-6, IL 1-Beta, lactic acid, and MDA values were significantly decreased in the FIP+digitoxin group compared to the FIP+Saline group. When the same groups were examined, histological improvements such as decrease in alveolar inflammation and decrease in septal thickening in the digitoxin group and thorax CT were found to be significantly higher in the Hounsfield unit digitoxin group compared to the Saline group. Conclusion: Digitoxin has shown biochemical improvement in sepsis with all known mechanisms of action, and healing effects in both computerized tomography and histology in the lung.